CHRS · Company research
Coherus Oncology, Inc. Common Stock (CHRS): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 1.01 | $133,543,540.98 | 50620540.98 | 0.74598568650907013284 | — | — | 10.4756464527769062 | 2.1950679013116802 | — |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.